GT Biopharma Inc (GTBP) financials · $17.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
GT Biopharma Inc (GTBP) $17.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$12.4M | -$14.4M |
| Net Income | -$28.4M | -$13.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.32M | $4.23M |
| Current Assets | $4.32M | $4.23M |
| Cash & Equivalents | $2.53M | $3.95M |
| Total Liabilities | $1.32M | $5.90M† |
| Current Liabilities | $1.32M | $5.90M |
| Shareholders' Equity | $3.00M | -$1.67M |
| Retained Earnings | -$700.8M | -$695.2M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.9M | -$12.9M |
| Investing Cash Flow | N/A | $12.9M |
| Financing Cash Flow | $15.8M | $2.98M |
| Dividends Paid | $229.0K | N/A |
| Net Change in Cash | $2.86M | $2.96M |
FAQ
What is GTBP P/E and revenue?
GT Biopharma Inc (GTBP) $17.4M cap.
What is GTBP revenue?
GTBP income-statement cache has no revenue figure yet.
Is GTBP profitable?
GT Biopharma Inc last cached net income is -$28.4M (FY2025).
What are GTBP total assets?
GT Biopharma Inc last cached total assets are $4.32M (FY2025).
What is GTBP free cash flow?
No cached cash-flow row for GTBP yet.
Not investment advice. Cached statements, not a live tape.